Searchable abstracts of presentations at key conferences in endocrinology

ea0043oc60 | Translational and Preclinical Trend in Diabetes | WCTD2016

Glucose transporters and C peptide role in diabetes control a preclinical review of literature

Pham Thuy , Dao Marvin , Singh Mukunda

Background: C-peptide therapy ameliorates sensory nerve function in T1DM neuropathy. Prolonged GLUT-4 translocation and delayed counter regulation can induce hypoglycemia. GLUT-2 protein is the primary hepatic liver transporter related to hepatic glucose regulation it also plays a role on glucose sensing by pancreatic beta cells, via hepatoportal sensors controlling the autonomic nervous system and stimulates glucagon secretion.Objective: To discuss the ...

ea0025p32 | Clinical biochemistry | SFEBES2011

Significance of insulin-C-peptide ratio in the diagnostic algorithm for endogenous hyperinsulinaemia

Sugunendran Suma , Narayanan Deepa , Shafiq Waqas , Malik Mohamed , Sathyapalan Thozhukat

Background: Insulin, derived from a single chain precursor pro-insulin, is cleaved by convertases to form insulin (t1/2 – 4 min) and C-peptide (t1/2 – 30 min). The ratio of insulin to C-peptide levels, which is usually less than one, is reversed in presence of exogenous insulin and insulin autoimmune syndrome. We present the significance of insulin-C-peptide ratio (ICR) in the diagnostic algorithm for the investigation of endogenous hyperinsulinaemia.<p class="ab...

ea0029p1034 | Male Reproduction | ICEECE2012

G protein-coupled estrogen receptor 1- and estrogen receptor α-dependent pathways regulate spermatocytes apoptosis

Chimento A. , Sirianni R. , Casaburi I. , Ruggiero C. , Maggiolini M. , Ando S. , Pezzi V.

In mammals, spontaneous apoptosis is observed particularly in differentiating spermatogonia and spermatocytes. We have previously demonstrated that 17β-estradiol (E2) in primary rat pachytene spermatocytes (PS) binds ESR1 and GPER1 to activate EGFR/ERK/c-Jun pathway leading to up regulation of bax, a pro-apoptotic factor. Aim of this study was to clarify the effector pathway(s) controlling spermatocytes apoptosis using as model GC-2 cells, an immortalized mouse...

ea0026p80 | Endocrine tumours and neoplasia | ECE2011

Mitotane reduces the chemoresistance phenotype in an adrenocortical carcinoma cell line

Gagliano T , Robustelli A R , Mole D , degli Uberti E , Zatelli M C

Adrenocortical carcinoma (ACC), a rare tumor, with incidence of 1–2 per million population annually, has a bimodal distribution by age, with cases clustering in children under 6, and in adults 30–40 years old. ACC has a dismal prognosis. The only curative treatment is complete surgical excision of the tumor, but late diagnosis prevents surgical cure, since ACC frequently recurs and metastasize. Chemotherapy is frequently ineffective, due to the overexpression of the ...

ea0022p283 | Diabetes | ECE2010

Impact of the SUR1 16-3 C/T and INSR His 1085 C/T genetic variability on type 2 diabetes mellitus development

Katalinic Darko , Nikolac Nora , Zjacic-Rotkvic Vanja , Topic Elizabeta , Solter Miljenko , Plestina Stjepko

Background: Type 2 diabetes (T2D), which is multifactorial, inherited and progressive chronic disorder, is characterised by hyperglycemia due to defects in insulin secretion and action. The sulfonylurea receptor (SUR1) and the insulin receptor (INSR) are critical elements in insulin-signalling pathways, and mutations in the SUR1 and INSR genes have been reported to have a role in determining susceptibility to T2D.The aim was to study whether the -3 C/T p...

ea0050ep099 | Reproduction | SFEBES2017

Extremely low HDL-C in a patient with premature ovarian failure: case presentation

Hilma Ana Maria , Gogoi Adriana

During menopause, plasma lipids change in an unfavourable way to a more atherogenic pattern with, increased total and LDL-cholesterol and decreased HDL cholesterol concentrations. Women with POI show increased cardiovascular morbidity and mortality regardless of the cause of the ovarian insufficiency. The treatment of premature ovarian failure in patients presenting extremely low HLD-C is a real challenge.We present the case of a 29 ye...

ea0050ep099 | Reproduction | SFEBES2017

Extremely low HDL-C in a patient with premature ovarian failure: case presentation

Hilma Ana Maria , Gogoi Adriana

During menopause, plasma lipids change in an unfavourable way to a more atherogenic pattern with, increased total and LDL-cholesterol and decreased HDL cholesterol concentrations. Women with POI show increased cardiovascular morbidity and mortality regardless of the cause of the ovarian insufficiency. The treatment of premature ovarian failure in patients presenting extremely low HLD-C is a real challenge.We present the case of a 29 ye...

ea0090ep375 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Statin Treatment in Children and Adolescents with Elevated LDL-c in Patient with Normoglycaemia and Dysglycaemia

Helal Radwa , Ali Tomader , Khaled Rayan , Lessan Nader

Background: The obesity prevalence surge in children and adolescents is associated with dysglycaemia, dyslipidaemia and long-term cardiovascular complications. Use of lipid-lowering medications1 has been recommended following lifestyle modifications. We aim to investigate the demographic, and changes in LDL-c, in these young patients, in the presence and absence of dysglycaemia.Methods: Complete lipid profiles of patients (≤19 years old)...

ea0026p624 | Clinical case reports | ECE2011

17β-hydroxysteroid dehydrogenase type 3 deficiency: a new case of a rare disease with an uncommon gene mutation

Galdiero M , Vitale P , Cariati F , Grasso L F S , Cozzolino A , Simeoli C , Afeltra L , Piscopo C , Rossi R , Melis D , Alviggi C , Lombardi G , Colao A , Pivonello R

Deficiency of 17β-hydroxysteroid dehydrogenase type 3 (17βHSD3), an enzyme converting androstenedione (A) to testosterone (T) in the Leydig cells of the testis, is a rare cause of autosomal recessive 46,XY disorders of sexual development (DSD). A 18-year-old phenotypically female patient presented with primary amenorrhea. She had deep voice, macrocephaly, broad forehead, enlarged nasal tip, macrostomia, facial acne, gynecomastia, left-convex dorsal scoliosis, hypopla...

ea0029p1630 | Thyroid (non-cancer) | ICEECE2012

Beta (CCL2) and alpha (CXCL10) chemokines modulation by cytokines and by peroxisome proliferator-activated receptor-alpha agonists in Graves’ ophthalmopathy

Antonelli A. , Ferrari S. , Sellari-Franeschini S. , Corrado A. , Mancusi C. , Ferrini M. , Ferrannini E. , Fallahi P.

Introduction: No study has evaluated the effect of cytokines on the prototype beta chemokine (C-C motif) ligand (CCL)2 in Graves’ ophthalmopathy (GO), nor of peroxisome proliferator-activated receptor (PPAR)alpha activation on this chemokine secretion in fibroblasts or preadipocytes in GO.Design and methods: We have tested the interferon (IFN)gamma and tumor necrosis factor (TNF)alpha effect on CCL2, and for comparison on the prototype alpha chemoki...